Fighting Cancer: A Compelling Case for Artificial Intelligence in Genomics
Artificial intelligence (AI) shows promise in its use as a part of routine clinical guidance. Pathologists leverage AI to provide expertly validated, up-to-date, comprehensive content to enable clinical reporting linking patients' sequencing results to potential therapeutic options using information extracted from medical literature and knowledge bases. This approach, which once required laborious literature searching by a team of bioinformaticians and oncologists, can now be completed in a fraction of the time.
Read this paper to learn how oncologists using IBM® Watson® for Genomics can quickly view insights from genomic data analysis which can be used to help them create personalized treatment plans for patients by:
- Classifying cancer-causing mutations from a publicly available database
- Mapping those mutations to therapeutic options using information extracted from the medical literature and knowledge bases
- Helping save time